Annual Drug Patent Expirations for MYCAMINE
Mycamine is a drug marketed by Astellas and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for MYCAMINE.
The generic ingredient in MYCAMINE is micafungin sodium. One supplier is listed for this compound. Additional details are available on the micafungin sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
